echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > New investment of $180 million, Roche Diagnostics deepens china layout

    New investment of $180 million, Roche Diagnostics deepens china layout

    • Last Update: 2020-05-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    REVIEW: cumulative total investment of $ 479 million, Roche further increase its investment in the Suzhou Industrial Park Roche DiagnosticsAsia-Pacific R & D center and production base Recently, Roche announced that it will further increase investment it is located in the Suzhou industrial Park Roche diagnostics Asia-Pacific R & D center and production base, plans to increase total investment of 180 million US dollars, the cumulative total investment of $ 479 million, the capital increase will further deepen the strategic layout of Roche diagnostics in China, but also confirms once again the Roche diagnostics root in China, dedicated to the Chinese medical industry co-development for the benefit of long-term commitment to China and the Asia-Pacific patientsnew investment will be used for in vitro diagnostic reagents production and construction of various product lines and transfer projects including the organization of diagnostic reagents and staining platforms, including professional diagnostic reagentsAs the world leader in in vitro diagnostics, Roche Diagnostics is committed to providing advanced diagnostic solutions for the global patients, hospitals and laboratoriesDuring the fight against the global epidemic COVID-19's, Roche Diagnostics rapid response, research and development and to provide cobasSARS-CoV-2 nucleic acid qualitative detection [1] and Elecsys®Anti-SARS-CoV-2 antibody detection [2]Future, Roche Diagnostics Asia-Pacific R & D center and production base is also expected to play an important role in the global fight against the epidemic COVID-19, the production in China and other Asia-Pacific countries and supply detection productsChina is one of the Roche Group's global strategic focus, Roche Diagnostics has always been practicing a long-term commitment to the Chinese market and support the development of China's medical industry, bringing innovation to Chinese patients, accurate detection products, "Chinese health "the contribute to the buildingThe new investment will further boost Roche Diagnostics deepen the strategic layout in China, to enhance the ability to respond to market Roche Diagnostics, bringing the wider areas of China and the Asia-Pacific's high quality testing productsFuture, Roche Diagnostics will continue to explore the possibility of landing more projects in China, and work together parties to actively participate in the construction of medical innovation projects, with a view to more cutting-edge in vitro diagnostic solutions into China, for the benefit of Chinese patientsEditor: Meng MengRelated Tags:National, Roche, Chinese market
    0

    0
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.